LivingGLP1
Study S001479

GLOW (GLP-1 Plus Lifestyle for Overall Wellness)

Registration

Registration
NCT06977438
Acronym
GLOW
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
TRIPLE
Status
NOT_YET_RECRUITING
Enrollment
1020
Start
2026-10-15
Primary completion
2031-01-31
Lead sponsor
University of Minnesota
Conditions
Obesity, Childhood
Interventions
DRUG:Semaglutide
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Body Mass Index (BMI) Reduction [24 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.